nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0805	0.178	CbGbCtD
Paroxetine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0594	0.131	CbGbCtD
Paroxetine—ABCB1—Betamethasone—ankylosing spondylitis	0.0524	0.116	CbGbCtD
Paroxetine—ABCB1—Prednisolone—ankylosing spondylitis	0.0517	0.114	CbGbCtD
Paroxetine—ABCB1—Prednisone—ankylosing spondylitis	0.0488	0.108	CbGbCtD
Paroxetine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.045	0.0994	CbGbCtD
Paroxetine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0314	0.0693	CbGbCtD
Paroxetine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0305	0.0673	CbGbCtD
Paroxetine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0287	0.0634	CbGbCtD
Paroxetine—ABCB1—Methotrexate—ankylosing spondylitis	0.0245	0.0541	CbGbCtD
Paroxetine—Shock—Triamcinolone—ankylosing spondylitis	0.000309	0.000565	CcSEcCtD
Paroxetine—Insomnia—Prednisolone—ankylosing spondylitis	0.000309	0.000565	CcSEcCtD
Paroxetine—Alopecia—Prednisone—ankylosing spondylitis	0.000309	0.000565	CcSEcCtD
Paroxetine—Shock—Methylprednisolone—ankylosing spondylitis	0.000309	0.000564	CcSEcCtD
Paroxetine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000308	0.000563	CcSEcCtD
Paroxetine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000308	0.000562	CcSEcCtD
Paroxetine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000307	0.000561	CcSEcCtD
Paroxetine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000307	0.000561	CcSEcCtD
Paroxetine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000307	0.000561	CcSEcCtD
Paroxetine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000307	0.000561	CcSEcCtD
Paroxetine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000307	0.000561	CcSEcCtD
Paroxetine—Mental disorder—Prednisone—ankylosing spondylitis	0.000306	0.00056	CcSEcCtD
Paroxetine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000306	0.00056	CcSEcCtD
Paroxetine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000305	0.000557	CcSEcCtD
Paroxetine—Erythema—Prednisone—ankylosing spondylitis	0.000304	0.000556	CcSEcCtD
Paroxetine—Malnutrition—Prednisone—ankylosing spondylitis	0.000304	0.000556	CcSEcCtD
Paroxetine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000304	0.000555	CcSEcCtD
Paroxetine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000304	0.000555	CcSEcCtD
Paroxetine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000303	0.000554	CcSEcCtD
Paroxetine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000303	0.000553	CcSEcCtD
Paroxetine—Convulsion—Betamethasone—ankylosing spondylitis	0.000303	0.000553	CcSEcCtD
Paroxetine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000302	0.000552	CcSEcCtD
Paroxetine—Hypertension—Betamethasone—ankylosing spondylitis	0.000302	0.000552	CcSEcCtD
Paroxetine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000298	0.000544	CcSEcCtD
Paroxetine—Myalgia—Betamethasone—ankylosing spondylitis	0.000298	0.000544	CcSEcCtD
Paroxetine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000297	0.000542	CcSEcCtD
Paroxetine—Anxiety—Betamethasone—ankylosing spondylitis	0.000297	0.000542	CcSEcCtD
Paroxetine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000294	0.000537	CcSEcCtD
Paroxetine—Discomfort—Betamethasone—ankylosing spondylitis	0.000294	0.000537	CcSEcCtD
Paroxetine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000294	0.000537	CcSEcCtD
Paroxetine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000293	0.000536	CcSEcCtD
Paroxetine—Pain—Prednisolone—ankylosing spondylitis	0.000292	0.000534	CcSEcCtD
Paroxetine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000292	0.000534	CcSEcCtD
Paroxetine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000292	0.000534	CcSEcCtD
Paroxetine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00029	0.00053	CcSEcCtD
Paroxetine—Vision blurred—Prednisone—ankylosing spondylitis	0.000287	0.000524	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000286	0.000523	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000286	0.000522	CcSEcCtD
Paroxetine—Oedema—Betamethasone—ankylosing spondylitis	0.000285	0.000521	CcSEcCtD
Paroxetine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000285	0.000521	CcSEcCtD
Paroxetine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000285	0.000521	CcSEcCtD
Paroxetine—Oedema—Dexamethasone—ankylosing spondylitis	0.000285	0.000521	CcSEcCtD
Paroxetine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000284	0.00052	CcSEcCtD
Paroxetine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000284	0.000519	CcSEcCtD
Paroxetine—Infection—Dexamethasone—ankylosing spondylitis	0.000283	0.000518	CcSEcCtD
Paroxetine—Infection—Betamethasone—ankylosing spondylitis	0.000283	0.000518	CcSEcCtD
Paroxetine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000282	0.000516	CcSEcCtD
Paroxetine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000282	0.000516	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000282	0.000515	CcSEcCtD
Paroxetine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000282	0.000515	CcSEcCtD
Paroxetine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000282	0.000515	CcSEcCtD
Paroxetine—Anaemia—Prednisone—ankylosing spondylitis	0.000281	0.000514	CcSEcCtD
Paroxetine—Shock—Dexamethasone—ankylosing spondylitis	0.000281	0.000513	CcSEcCtD
Paroxetine—Shock—Betamethasone—ankylosing spondylitis	0.000281	0.000513	CcSEcCtD
Paroxetine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00028	0.000512	CcSEcCtD
Paroxetine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00028	0.000511	CcSEcCtD
Paroxetine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00028	0.000511	CcSEcCtD
Paroxetine—Agitation—Prednisone—ankylosing spondylitis	0.00028	0.000511	CcSEcCtD
Paroxetine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000279	0.00051	CcSEcCtD
Paroxetine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000279	0.00051	CcSEcCtD
Paroxetine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000278	0.000509	CcSEcCtD
Paroxetine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000278	0.000509	CcSEcCtD
Paroxetine—Angioedema—Prednisone—ankylosing spondylitis	0.000278	0.000508	CcSEcCtD
Paroxetine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000277	0.000506	CcSEcCtD
Paroxetine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000276	0.000505	CcSEcCtD
Paroxetine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000276	0.000505	CcSEcCtD
Paroxetine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000276	0.000504	CcSEcCtD
Paroxetine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000276	0.000504	CcSEcCtD
Paroxetine—Malaise—Prednisone—ankylosing spondylitis	0.000275	0.000502	CcSEcCtD
Paroxetine—Vertigo—Prednisone—ankylosing spondylitis	0.000274	0.0005	CcSEcCtD
Paroxetine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000273	0.000499	CcSEcCtD
Paroxetine—Syncope—Prednisone—ankylosing spondylitis	0.000273	0.000499	CcSEcCtD
Paroxetine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000272	0.000498	CcSEcCtD
Paroxetine—Urticaria—Prednisolone—ankylosing spondylitis	0.000272	0.000496	CcSEcCtD
Paroxetine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000271	0.000496	CcSEcCtD
Paroxetine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000271	0.000495	CcSEcCtD
Paroxetine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00027	0.000494	CcSEcCtD
Paroxetine—Pain—Triamcinolone—ankylosing spondylitis	0.000269	0.000491	CcSEcCtD
Paroxetine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000268	0.000489	CcSEcCtD
Paroxetine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000267	0.000487	CcSEcCtD
Paroxetine—Hypotension—Betamethasone—ankylosing spondylitis	0.000267	0.000487	CcSEcCtD
Paroxetine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000265	0.000485	CcSEcCtD
Paroxetine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000264	0.000482	CcSEcCtD
Paroxetine—Convulsion—Prednisone—ankylosing spondylitis	0.000264	0.000482	CcSEcCtD
Paroxetine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000263	0.000481	CcSEcCtD
Paroxetine—Hypertension—Prednisone—ankylosing spondylitis	0.000263	0.00048	CcSEcCtD
Paroxetine—Chills—Methotrexate—ankylosing spondylitis	0.000262	0.000479	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00026	0.000475	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00026	0.000475	CcSEcCtD
Paroxetine—Arthralgia—Prednisone—ankylosing spondylitis	0.000259	0.000474	CcSEcCtD
Paroxetine—Myalgia—Prednisone—ankylosing spondylitis	0.000259	0.000474	CcSEcCtD
Paroxetine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000259	0.000473	CcSEcCtD
Paroxetine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000259	0.000472	CcSEcCtD
Paroxetine—Anxiety—Prednisone—ankylosing spondylitis	0.000258	0.000472	CcSEcCtD
Paroxetine—Alopecia—Methotrexate—ankylosing spondylitis	0.000258	0.000472	CcSEcCtD
Paroxetine—Insomnia—Betamethasone—ankylosing spondylitis	0.000258	0.000472	CcSEcCtD
Paroxetine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000258	0.000472	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000257	0.00047	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000257	0.000469	CcSEcCtD
Paroxetine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000256	0.000468	CcSEcCtD
Paroxetine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000256	0.000468	CcSEcCtD
Paroxetine—Discomfort—Prednisone—ankylosing spondylitis	0.000256	0.000468	CcSEcCtD
Paroxetine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000256	0.000468	CcSEcCtD
Paroxetine—Erythema—Methotrexate—ankylosing spondylitis	0.000254	0.000465	CcSEcCtD
Paroxetine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000254	0.000465	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000252	0.00046	CcSEcCtD
Paroxetine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000251	0.000459	CcSEcCtD
Paroxetine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000251	0.000459	CcSEcCtD
Paroxetine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00025	0.000456	CcSEcCtD
Paroxetine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000249	0.000455	CcSEcCtD
Paroxetine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000249	0.000455	CcSEcCtD
Paroxetine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000249	0.000454	CcSEcCtD
Paroxetine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000248	0.000454	CcSEcCtD
Paroxetine—Oedema—Prednisone—ankylosing spondylitis	0.000248	0.000454	CcSEcCtD
Paroxetine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000248	0.000453	CcSEcCtD
Paroxetine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000248	0.000453	CcSEcCtD
Paroxetine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000248	0.000453	CcSEcCtD
Paroxetine—Infection—Prednisone—ankylosing spondylitis	0.000247	0.000451	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000246	0.00045	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000246	0.00045	CcSEcCtD
Paroxetine—Back pain—Methotrexate—ankylosing spondylitis	0.000246	0.00045	CcSEcCtD
Paroxetine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000246	0.000449	CcSEcCtD
Paroxetine—Fatigue—Betamethasone—ankylosing spondylitis	0.000246	0.000449	CcSEcCtD
Paroxetine—Shock—Prednisone—ankylosing spondylitis	0.000244	0.000447	CcSEcCtD
Paroxetine—Pain—Betamethasone—ankylosing spondylitis	0.000244	0.000446	CcSEcCtD
Paroxetine—Pain—Dexamethasone—ankylosing spondylitis	0.000244	0.000446	CcSEcCtD
Paroxetine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000244	0.000445	CcSEcCtD
Paroxetine—Tachycardia—Prednisone—ankylosing spondylitis	0.000242	0.000443	CcSEcCtD
Paroxetine—Skin disorder—Prednisone—ankylosing spondylitis	0.000241	0.000441	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00024	0.000439	CcSEcCtD
Paroxetine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00024	0.000438	CcSEcCtD
Paroxetine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000236	0.000431	CcSEcCtD
Paroxetine—Anaemia—Methotrexate—ankylosing spondylitis	0.000235	0.00043	CcSEcCtD
Paroxetine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000235	0.00043	CcSEcCtD
Paroxetine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000235	0.00043	CcSEcCtD
Paroxetine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000233	0.000426	CcSEcCtD
Paroxetine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000233	0.000426	CcSEcCtD
Paroxetine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000232	0.000423	CcSEcCtD
Paroxetine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000231	0.000422	CcSEcCtD
Paroxetine—Malaise—Methotrexate—ankylosing spondylitis	0.000229	0.000419	CcSEcCtD
Paroxetine—Vertigo—Methotrexate—ankylosing spondylitis	0.000229	0.000418	CcSEcCtD
Paroxetine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000228	0.000416	CcSEcCtD
Paroxetine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000227	0.000414	CcSEcCtD
Paroxetine—Urticaria—Betamethasone—ankylosing spondylitis	0.000227	0.000414	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000226	0.000414	CcSEcCtD
Paroxetine—Dizziness—Prednisolone—ankylosing spondylitis	0.000226	0.000413	CcSEcCtD
Paroxetine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000226	0.000412	CcSEcCtD
Paroxetine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000226	0.000412	CcSEcCtD
Paroxetine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000226	0.000412	CcSEcCtD
Paroxetine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000226	0.000412	CcSEcCtD
Paroxetine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000226	0.000412	CcSEcCtD
Paroxetine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000225	0.000411	CcSEcCtD
Paroxetine—Insomnia—Prednisone—ankylosing spondylitis	0.000225	0.000411	CcSEcCtD
Paroxetine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000223	0.000408	CcSEcCtD
Paroxetine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000222	0.000407	CcSEcCtD
Paroxetine—Cough—Methotrexate—ankylosing spondylitis	0.000222	0.000406	CcSEcCtD
Paroxetine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000222	0.000406	CcSEcCtD
Paroxetine—Convulsion—Methotrexate—ankylosing spondylitis	0.00022	0.000403	CcSEcCtD
Paroxetine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000219	0.0004	CcSEcCtD
Paroxetine—Chest pain—Methotrexate—ankylosing spondylitis	0.000217	0.000396	CcSEcCtD
Paroxetine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000217	0.000396	CcSEcCtD
Paroxetine—Myalgia—Methotrexate—ankylosing spondylitis	0.000217	0.000396	CcSEcCtD
Paroxetine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000216	0.000395	CcSEcCtD
Paroxetine—Rash—Prednisolone—ankylosing spondylitis	0.000216	0.000394	CcSEcCtD
Paroxetine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000215	0.000394	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000215	0.000393	CcSEcCtD
Paroxetine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000215	0.000392	CcSEcCtD
Paroxetine—Fatigue—Prednisone—ankylosing spondylitis	0.000214	0.000391	CcSEcCtD
Paroxetine—Headache—Prednisolone—ankylosing spondylitis	0.000214	0.000391	CcSEcCtD
Paroxetine—Discomfort—Methotrexate—ankylosing spondylitis	0.000214	0.000391	CcSEcCtD
Paroxetine—Constipation—Prednisone—ankylosing spondylitis	0.000212	0.000388	CcSEcCtD
Paroxetine—Confusional state—Methotrexate—ankylosing spondylitis	0.000209	0.000383	CcSEcCtD
Paroxetine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000208	0.00038	CcSEcCtD
Paroxetine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000208	0.000379	CcSEcCtD
Paroxetine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000207	0.000379	CcSEcCtD
Paroxetine—Infection—Methotrexate—ankylosing spondylitis	0.000206	0.000377	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000205	0.000374	CcSEcCtD
Paroxetine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000205	0.000374	CcSEcCtD
Paroxetine—Asthenia—Betamethasone—ankylosing spondylitis	0.000205	0.000374	CcSEcCtD
Paroxetine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000204	0.000372	CcSEcCtD
Paroxetine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000203	0.000372	CcSEcCtD
Paroxetine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000203	0.000371	CcSEcCtD
Paroxetine—Nausea—Prednisolone—ankylosing spondylitis	0.000203	0.000371	CcSEcCtD
Paroxetine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000202	0.000369	CcSEcCtD
Paroxetine—Pruritus—Betamethasone—ankylosing spondylitis	0.000202	0.000369	CcSEcCtD
Paroxetine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000202	0.000369	CcSEcCtD
Paroxetine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000201	0.000367	CcSEcCtD
Paroxetine—Vomiting—Triamcinolone—ankylosing spondylitis	0.0002	0.000365	CcSEcCtD
Paroxetine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000199	0.000365	CcSEcCtD
Paroxetine—Rash—Triamcinolone—ankylosing spondylitis	0.000198	0.000362	CcSEcCtD
Paroxetine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000198	0.000362	CcSEcCtD
Paroxetine—Rash—Methylprednisolone—ankylosing spondylitis	0.000198	0.000361	CcSEcCtD
Paroxetine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000198	0.000361	CcSEcCtD
Paroxetine—Urticaria—Prednisone—ankylosing spondylitis	0.000197	0.000361	CcSEcCtD
Paroxetine—Headache—Triamcinolone—ankylosing spondylitis	0.000197	0.00036	CcSEcCtD
Paroxetine—Headache—Methylprednisolone—ankylosing spondylitis	0.000197	0.000359	CcSEcCtD
Paroxetine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000196	0.000359	CcSEcCtD
Paroxetine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000196	0.000359	CcSEcCtD
Paroxetine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000195	0.000357	CcSEcCtD
Paroxetine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000195	0.000357	CcSEcCtD
Paroxetine—Hypotension—Methotrexate—ankylosing spondylitis	0.000194	0.000355	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000189	0.000346	CcSEcCtD
Paroxetine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000189	0.000345	CcSEcCtD
Paroxetine—Dizziness—Betamethasone—ankylosing spondylitis	0.000189	0.000345	CcSEcCtD
Paroxetine—Insomnia—Methotrexate—ankylosing spondylitis	0.000188	0.000343	CcSEcCtD
Paroxetine—Nausea—Triamcinolone—ankylosing spondylitis	0.000187	0.000341	CcSEcCtD
Paroxetine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000186	0.000341	CcSEcCtD
Paroxetine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000186	0.000341	CcSEcCtD
Paroxetine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000185	0.000338	CcSEcCtD
Paroxetine—Somnolence—Methotrexate—ankylosing spondylitis	0.000185	0.000337	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000183	0.000335	CcSEcCtD
Paroxetine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000183	0.000334	CcSEcCtD
Paroxetine—Vomiting—Betamethasone—ankylosing spondylitis	0.000181	0.000331	CcSEcCtD
Paroxetine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000181	0.000331	CcSEcCtD
Paroxetine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00018	0.00033	CcSEcCtD
Paroxetine—Rash—Dexamethasone—ankylosing spondylitis	0.00018	0.000329	CcSEcCtD
Paroxetine—Rash—Betamethasone—ankylosing spondylitis	0.00018	0.000329	CcSEcCtD
Paroxetine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00018	0.000328	CcSEcCtD
Paroxetine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00018	0.000328	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000179	0.000328	CcSEcCtD
Paroxetine—Fatigue—Methotrexate—ankylosing spondylitis	0.000179	0.000327	CcSEcCtD
Paroxetine—Headache—Betamethasone—ankylosing spondylitis	0.000179	0.000327	CcSEcCtD
Paroxetine—Headache—Dexamethasone—ankylosing spondylitis	0.000179	0.000327	CcSEcCtD
Paroxetine—Asthenia—Prednisone—ankylosing spondylitis	0.000178	0.000326	CcSEcCtD
Paroxetine—Pain—Methotrexate—ankylosing spondylitis	0.000178	0.000324	CcSEcCtD
Paroxetine—Pruritus—Prednisone—ankylosing spondylitis	0.000176	0.000321	CcSEcCtD
Paroxetine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000171	0.000313	CcSEcCtD
Paroxetine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00017	0.000311	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00017	0.00031	CcSEcCtD
Paroxetine—Nausea—Dexamethasone—ankylosing spondylitis	0.000169	0.00031	CcSEcCtD
Paroxetine—Nausea—Betamethasone—ankylosing spondylitis	0.000169	0.00031	CcSEcCtD
Paroxetine—Urticaria—Methotrexate—ankylosing spondylitis	0.000165	0.000301	CcSEcCtD
Paroxetine—Dizziness—Prednisone—ankylosing spondylitis	0.000164	0.0003	CcSEcCtD
Paroxetine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000164	0.0003	CcSEcCtD
Paroxetine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000164	0.0003	CcSEcCtD
Paroxetine—Vomiting—Prednisone—ankylosing spondylitis	0.000158	0.000289	CcSEcCtD
Paroxetine—Rash—Prednisone—ankylosing spondylitis	0.000157	0.000286	CcSEcCtD
Paroxetine—Dermatitis—Prednisone—ankylosing spondylitis	0.000157	0.000286	CcSEcCtD
Paroxetine—Headache—Prednisone—ankylosing spondylitis	0.000156	0.000284	CcSEcCtD
Paroxetine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000153	0.00028	CcSEcCtD
Paroxetine—Asthenia—Methotrexate—ankylosing spondylitis	0.000149	0.000272	CcSEcCtD
Paroxetine—Nausea—Prednisone—ankylosing spondylitis	0.000148	0.00027	CcSEcCtD
Paroxetine—Pruritus—Methotrexate—ankylosing spondylitis	0.000147	0.000268	CcSEcCtD
Paroxetine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000142	0.00026	CcSEcCtD
Paroxetine—Dizziness—Methotrexate—ankylosing spondylitis	0.000137	0.000251	CcSEcCtD
Paroxetine—Vomiting—Methotrexate—ankylosing spondylitis	0.000132	0.000241	CcSEcCtD
Paroxetine—Rash—Methotrexate—ankylosing spondylitis	0.000131	0.000239	CcSEcCtD
Paroxetine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000131	0.000239	CcSEcCtD
Paroxetine—Headache—Methotrexate—ankylosing spondylitis	0.00013	0.000238	CcSEcCtD
Paroxetine—Nausea—Methotrexate—ankylosing spondylitis	0.000123	0.000225	CcSEcCtD
